Groace 100 Capsule contains Acebrophylline 100 mg, a bronchodilator and mucolytic agent used primarily in the management of respiratory disorders characterized by bronchospasm and excessive mucus production. Acebrophylline acts by relaxing the smooth muscles of the airways, thereby facilitating easier breathing, while also exhibiting anti-inflammatory properties that help reduce airway inflammation. It is commonly prescribed for conditions such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. The dual action of Acebrophylline improves mucociliary clearance, enhances expectoration, and alleviates symptoms like wheezing, breathlessness, and cough. Groace 100 Capsule is typically administered orally, with dosage adjusted according to the severity of the condition and patient response. It is generally well-tolerated; however, patients should be monitored for potential adverse effects such as gastrointestinal discomfort, headache, or hypersensitivity reactions. Caution is advised in patients with pre-existing cardiac conditions or hypersensitivity to xanthine derivatives. Groace 100 Capsule should be used under medical supervision, ensuring appropriate evaluation of respiratory status and monitoring for therapeutic efficacy and safety. This medication contributes significantly to improving respiratory function and quality of life in patients with obstructive airway diseases.